Analytical And Quality Control
-
Applying AI And Rapid Prototyping To Media And Process Development
3/26/2026
Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.
-
Inside Bioprocessing: Multi-Omics
6/16/2025
Dive into multi-omics analysis with Paul Gulde, Chengjian Tu, and Femi Egbebi. In biopharmaceutical production, meeting the unique nutrient requirements of the cells is central to achieving optimal results.
-
Leveraging Rapid Sterility Testing To Advance Cell Therapy Production
6/23/2025
Explore the crucial role of rapid sterility testing in cell therapy manufacturing. This presentation delves into the benefits of swift, accurate detection for product quality and patient safety.
-
Cell Culture Media Manufacturing, Grand Island, NY
11/4/2025
Learn more about our cell culture media manufacturing global network, including details of the Grand Island, New York sites capacity expansion supporting the bioprocessing industrys rapidly growing needs.
-
Validation Of A qPCR Assay For Host Cell DNA Quantitation
6/9/2025
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
-
Multi-Omics And Bioinformatics In Cell Culture Media Design
6/16/2025
Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.
-
Dry Powder Media Manufacturing Grand Island Expansion
11/5/2025
Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.
-
Introducing The Applied Biosystems Resdnaseq Quantitative DNA System
11/20/2025
Thermo Fisher Scientific's portfolio of resDNASEQ solutions is here to meet your specific needs enabling you to test for residual host cell DNA and release your biotherapeutics with confidence in safety and confidence in product quality.
-
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration
8/20/2025
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
-
Key Attributes To Monitor During Cell Line Development Of Complex Proteins
9/13/2024
In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, panelists discuss key attributes to monitor during cell line development processes.